These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35759452)

  • 21. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
    Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
    Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Based Virtual Screening and Discovery of New Bi-functional DAPK1 Inhibitors.
    Talwar P; Singh P; Ravanan P
    Mol Biotechnol; 2024 Apr; 66(4):876-901. PubMed ID: 37351834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
    Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
    J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Rho-kinase inhibitors by docking-based virtual screening.
    Shen M; Yu H; Li Y; Li P; Pan P; Zhou S; Zhang L; Li S; Lee SM; Hou T
    Mol Biosyst; 2013 Jun; 9(6):1511-21. PubMed ID: 23549429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes.
    Farag AK; Roh EJ
    Med Res Rev; 2019 Jan; 39(1):349-385. PubMed ID: 29949198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DAPK3 suppresses acini morphogenesis and is required for mouse development.
    Kocher BA; White LS; Piwnica-Worms D
    Mol Cancer Res; 2015 Feb; 13(2):358-67. PubMed ID: 25304685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an
    Firoz A; Talwar P
    J Biomol Struct Dyn; 2024 Jul; 42(11):5686-5698. PubMed ID: 37387600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacophore development, drug-likeness analysis, molecular docking, and molecular dynamics simulations for identification of new CK2 inhibitors.
    Hammad S; Bouaziz-Terrachet S; Meghnem R; Meziane D
    J Mol Model; 2020 May; 26(6):160. PubMed ID: 32472293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations.
    Shafie A; Khan S; Zehra ; Mohammad T; Anjum F; Hasan GM; Yadav DK; Hassan MI
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy.
    Li GM; Li L; Li MQ; Chen X; Su Q; Deng ZJ; Liu HB; Li B; Zhang WH; Jia YX; Wang WJ; Ma JY; Zhang HL; Xie D; Zhu XF; He YL; Guan XY; Bi J
    Cell Death Differ; 2021 Mar; 28(3):952-967. PubMed ID: 33037394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Death-associated protein kinase 3 deficiency alleviates vascular calcification via AMPK-mediated inhibition of endoplasmic reticulum stress.
    Li KX; Du Q; Wang HP; Sun HJ
    Eur J Pharmacol; 2019 Jun; 852():90-98. PubMed ID: 30851272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated docking and molecular dynamics simulation approach to discover potential inhibitors of activin receptor-like kinase 1.
    Jairajpuri DS; Mohammad T; Hussain A; Amir S; Fatima U; AlAjmi MF; Yadav DK; Hassan MI
    J Mol Recognit; 2024 Mar; 37(2):e3069. PubMed ID: 38053481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma.
    Adnan M; Jairajpuri DS; Chaddha M; Khan MS; Yadav DK; Mohammad T; Elasbali AM; Abu Al-Soud W; Hussain Alharethi S; Hassan MI
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.
    Shahroz MM; Sharma HK; Altamimi ASA; Alamri MA; Ali A; Ali A; Alqahtani S; Altharawi A; Alabbas AB; Alossaimi MA; Riadi Y; Firoz A; Afzal O
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals.
    Elbadawy M; Usui T; Yamawaki H; Sasaki K
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore modeling, molecular docking and molecular dynamics simulations toward identifying lead compounds for Chk1.
    Li Y; Peng J; Zhou Y; Li P; Li Y; Liu X; Siddique AN; Zhang L; Zuo Z
    Comput Biol Chem; 2018 Oct; 76():53-60. PubMed ID: 29940486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics.
    Anjum F; Sulaimani MN; Shafie A; Mohammad T; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Alsagaby SA; Yadav DK; Hassan MI
    RSC Adv; 2022 Mar; 12(13):7872-7882. PubMed ID: 35424745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.